Immatics NV (IMTX)
9.94
-0.04
(-0.40%)
USD |
NASDAQ |
Apr 30, 16:00
9.94
0.00 (0.00%)
After-Hours: 20:00
Immatics Net Income (TTM): -105.04M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -105.04M |
| September 30, 2023 | -90.42M |
| June 30, 2023 | -82.66M |
| March 31, 2023 | -70.72M |
| December 31, 2022 | 46.61M |
| September 30, 2022 | 40.94M |
| June 30, 2022 | 29.96M |
| March 31, 2022 | 12.87M |
| Date | Value |
|---|---|
| December 31, 2021 | -110.74M |
| September 30, 2021 | -112.97M |
| June 30, 2021 | -272.62M |
| March 31, 2021 | -263.82M |
| December 31, 2020 | -245.50M |
| September 30, 2020 | -240.36M |
| June 30, 2020 | -53.87M |
| March 31, 2020 | -37.96M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-272.62M
Minimum
Jun 2021
46.61M
Maximum
Dec 2022
-97.27M
Average
-86.54M
Median
Net Income (TTM) Benchmarks
| MorphoSys AG | -206.62M |
| Affimed NV | -114.68M |
| InflaRx NV | -46.12M |
| BioNTech SE | 999.74M |
| CureVac NV | -319.87M |